The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACADIA PHARMACEUTICALS INC COM 004225108   18,735 1,176,830 SH   SOLE   1,176,830 0 0
AFTERNEXT HEALTHTECH ACQUISITION CORP *W EXP 99/99/999 G01109126   28 366,666 SH   SOLE   366,666 0 0
ALGOMA STL GROUP INC COM 015658107   20,411 3,219,441 SH   SOLE   3,219,441 0 0
AMICUS THERAPEUTICS INC COM 03152W109   17,442 1,428,475 SH   SOLE   1,428,475 0 0
APELLIS PHARMACEUTICALS INC COM 03753U106   17,317 334,890 SH   SOLE   334,890 0 0
ARES ACQUISITION CORP *W EXP 99/99/999 G33032122   235 504,706 SH   SOLE   504,706 0 0
ARVINAS INC COM 04335A105   14,697 429,600 SH   SOLE   429,600 0 0
ASCENDIS PHARMA A/S SPONSORED ADR 04351P101   16,370 134,036 SH   SOLE   134,036 0 0
BERENSON ACQUISITION CORP I *W EXP 08/01/202 083690115   31 862,499 SH   SOLE   862,499 0 0
BILANDER ACQUISITION CORP *W EXP 05/19/202 09001T114   33 183,749 SH   SOLE   183,749 0 0
BRIDGETOWN HOLDINGS LTD *W EXP 09/30/202 G1355U121   103 895,000 SH   SOLE   895,000 0 0
CATALYST PARTNERS ACQUISITION *W EXP 05/12/202 G19550121   1 336,666 SH   SOLE   336,666 0 0
CEREVEL THERAPEUTICS HLDNG I COM 15678U128   16,315 517,287 SH   SOLE   517,287 0 0
CHURCHILL CAPITAL CORP V *W EXP 10/29/202 17144T115   49 612,000 SH   SOLE   612,000 0 0
CHURCHILL CAPITAL CORP VI *W EXP 02/17/202 17143W119   32 540,000 SH   SOLE   540,000 0 0
CHURCHILL CAPITAL CORP VII *W EXP 02/29/202 17144M110   27 548,000 SH   SOLE   548,000 0 0
COMPASS DIGITAL ACQUISITION CORP *W EXP 09/29/202 G2476C123   37 459,906 SH   SOLE   459,906 0 0
CONCORD ACQUISITION CORP II *W EXP 99/99/999 20607U116   47 408,333 SH   SOLE   408,333 0 0
CONYERS PARK III ACQUISITION CORP *W EXP 08/12/202 21289P110   85 571,666 SH   SOLE   571,666 0 0
CORSAIR PARTNERING CORP *W EXP 07/06/202 G2540H116   110 334,666 SH   SOLE   334,666 0 0
CRINETICS PHARMACEUTICALS IN COM 22663K107   15,056 822,745 SH   SOLE   822,745 0 0
CYTOKINETICS INC COM NEW 23282W605   18,456 402,793 SH   SOLE   402,793 0 0
DISH NETWORK CORPORATION NOTE 12/1 25470MAF6   9,645 15,000,000 PRN   SOLE   15,000,000 0 0
FIRST LIGHT ACQUISITION GROUP INC *W EXP 03/14/202 320703119   33 655,200 SH   SOLE   655,200 0 0
GALAPAGOS NV SPON ADR 36315X101   17,324 390,359 SH   SOLE   390,359 0 0
HOME PLATE ACQUISITION CORP *W EXP 09/30/202 43734R111   7 690,000 SH   SOLE   690,000 0 0
IOVANCE BIOTHERAPEUTICS INC COM 462260100   9,876 1,545,589 SH   SOLE   1,545,589 0 0
IVERIC BIO INC COM 46583P102   15,150 707,600 SH   SOLE   707,600 0 0
JAWS HURRICANE ACQUISITION CORP *W EXP 03/26/202 47201B111   62 387,249 SH   SOLE   387,249 0 0
LEVERE HOLDINGS CORP *W EXP 03/09/202 G5462L122   4 274,999 SH   SOLE   274,999 0 0
MARBLEGATE ACQUISITION CORP *W EXP 08/31/202 56608A113   29 735,000 SH   SOLE   735,000 0 0
PROTHENA CORP PLC SHS G72800108   19,455 322,900 SH   SOLE   322,900 0 0
RELAY THERAPEUTICS INC COM 75943R102   10,680 714,848 SH   SOLE   714,848 0 0
ROSS ACQUISITION CORP II *W EXP 02/01/202 G7641C114   22 439,666 SH   SOLE   439,666 0 0
SAGE THERAPEUTICS INC COM 78667J108   14,561 381,765 SH   SOLE   381,765 0 0
SAREPTA THERAPEUTICS INC COM 803607100   17,034 131,457 SH   SOLE   131,457 0 0
SENIOR CONNECT ACQUISITION COR *W EXP 12/31/202 81723H116   61 1,014,000 SH   SOLE   1,014,000 0 0
SKYDECK ACQUISITION CORP *W EXP 05/13/202 G82220115   7 361,756 SH   SOLE   361,756 0 0
SOLID BIOSCIENCES INC COM NEW 83422E204   1,176 218,562 SH   SOLE   218,562 0 0
SPRINGWORKS THERAPEUTICS INC COM 85205L107   16,724 643,000 SH   SOLE   643,000 0 0
SUMMIT HEALTHCARE ACQUISITION CORP *W EXP 06/03/202 G8566R110   139 489,999 SH   SOLE   489,999 0 0
SWIFTMERGE ACQUISITION CORP *W EXP 12/13/202 G63836111   36 490,000 SH   SOLE   490,000 0 0
TRAVERE THERAPEUTICS INC COM 89422G107   21,583 1,026,300 SH   SOLE   1,026,300 0 0
ZIMMER ENERGY TRANSITION ACQUISITION CORP *W EXP 06/16/202 989570114   68 358,270 SH   SOLE   358,270 0 0